As President of ACTRIMS and Chair of the Steering Committee of the Joint ACTRIMS-ECTRIMS Meeting, it is my great pleasure that I announce the 2014 Joint ACTRIMS-ECTRIMS conference to be held in Boston, Massachusetts (USA), from September 10th to the 13th.
Suhayl Dhib-Jalbut, MD Professor and Chairman, Department of Neurology RUTGERS-Robert Wood Johnson Medical School Chief, Neurology Services Robert Wood Johnson University Hospital (New Brunswick, New Jersey) President and Chairman, ACTRIMS
Jerry S. Wolinsky, MD Interim Chair, and Bartles Family and Opal C. Rankin Professor, Department of Neurology, and University of Texas Health Science Center at Houston and Director, Multiple Sclerosis Research Group and the Magnetic Resonance Imaging Analysis Center (Houston, Texas) Director and Chair, 2014 Joint ACTRIMS-ECTRIMS Meeting Teaching Program
On September 10-13, ACTRIMS and ECTRIMS will be jointly hosting MSBoston2014 – the world’s largest international conference exclusively devoted to research in multiple sclerosis and other demyelinating diseases. Held at the Hynes Convention Center in downtown Boston, this sixth triennial joint international meeting will attract close to 7,000 researchers and medical professionals, as well as companies involved in the development and commercialization of MS treatments and advocacy organizations that provide funding for research, programs and services for those living with MS.
ACTRIMS-ECTRIMS will be hosting their sixth triennial joint meeting, MSBoston2014, from September 10-13. In this video the President of ACTRIMS, Dr. Dhib-Jalbut, welcomes over 6,500 participants attending this conference -- the world's largest international meeting exclusively devoted to research in Multiple Sclerosis.
The International Progressive MS Alliance will host a press briefing at ACTRIMS-ECTRIMS, the world’s largest MS science meeting, to announce the recipients of its first round of research grants in the amount of € 22 million (nearly $30 million USD). The grants being awarded advance research and remove barriers to developing treatments for progressive MS.
ACTRIMS-ECTRIMS MSBoston2014 Late Breaking News Oral Presentations
On Thursday, September 11th at 8:30 a.m., MSBoston2014 -- the world’s largest international conference exclusively devoted to research in multiple sclerosis (MS) -- will host its opening ceremony with Dr. Dhib-Jalbut, President of ACTRIMS, providing an overarching look at the MS landscape. In his address, he will underscore the critical importance of MS research, the developments and breakthroughs that have been realized, and the difference these advances have made in the lives of those living with MS, as well as those caring for them. He will also speak of the challenges that lie ahead and new areas of research that will transform the field moving forward.
Oceans of Hope, a 20-metre yacht undertaking a global circumnavigation with a working crew including people living with MS, aims to change the perceptions of what it means to live with the disease. At the opening ceremony of MSBoston2014, on September 11th at 8:30 a.m., the crew led by Dr. Mikkel Anthonisen, will share a riveting video of their voyage, and speak of their extraordinary experiences during their transatlantic crossing.
Every three years ACTRIMS and ECTRIMS organize a joint meeting to encourage knowledge exchange and bring together MS professionals from around the world. The triennial joint meeting is alternately hosted in North America and Europe.
Schedule of Press Events at MSBoston2014
The International Progressive MS Alliance has awarded its first round of 22 research grants to investigators in 9 countries, with the goal of removing barriers to developing treatments for progressive MS. The Alliance is a worldwide collaborative focused on finding solutions to progressive forms of multiple sclerosis that have so far eluded the scientific community.
The International Progressive MS Alliance has awarded its first round of 22 research grants to investigators in 9 countries, with the goal of removing barriers to developing treatments for progressive MS. The Alliance is a worldwide collaborative focused on finding solutions to progressive forms of multiple sclerosis that have so far eluded the scientific community.
I am Dr. Suhayl Dhib-Jalbut, President of ACTRIMS, and on behalf of the President of ECTRIMS, Prof. Maria Trojano, it is my pleasure and honor to warmly welcome you to the sixth triennial Joint ACTRIMS-ECTRIMS Meeting - MSBoston2014.
On September 10-13 at the Hynes Convention Center in Boston, MA, ACTRIMS-ECTRIMS will host their joint triennial international meeting – MSBoston 2014, with over 8,000 participant from leading organizations in Europe, North America and other regions of the world convening to share, discuss and advance research in Multiple Sclerosis (MS). The meeting program will include topics as diverse as the underlying cause of MS, new emerging treatments and repair of the nervous system. MSBoston 2014 will provide journalists with an opportunity to hear about the latest advances in MS, speak with the leading experts, and interact with people living with MS who are also playing a major role in changing the perception of MS and enhancing understanding of this disease. ACTRIMS and ECTRIMS Steering Committee members will be available daily to media for overarching commentary on research in MS, new trends, latest study findings and new developments. Assistance will be available to reporters seeking to s
Oceans of Hope was created by the Sailing Sclerosis Foundation to change perceptions of multiple sclerosis by showing what is possible when people with a chronic disease are empowered to conquer their individual challenges. The 20-meter yacht, Oceans of Hope< is undertaking the first global circumnavigation by a crew of people with MS.
ACTRIMS Forum 2016, the first standalone event for the Americas Committee for Treatment and Research in Multiple Sclerosis, will feature the latest research results and bring together researchers and clinicians from the United States and Canada.
Jerry S. Wolinsky, M.D., will deliver the first annual Kenneth P. Johnson Memorial Lecture at ACTRIMS Forum 2016, Feb. 18 - 20, 2016, in New Orleans. Americas Committee for Treatment and Research in Multiple Sclerosis is hosting its first-ever standalone forum for researchers and clinicians to share the latest developments.
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? Roberta Magliozzi, Ph.D., Imperial College, London, UK
Jennifer S. Graves M.D., Ph.D., University of California at San Francisco will present one of three late-breaking abstracts at ACTRIMS 2016
More than 500 clinicians and researchers are meeting in New Orleans to share the latest information about progressive multiple sclerosis.
Opportunities for young investigators to present their findings and consult with established researchers and clinicians were among the primary goals of ACTRIMS Forum 2016. The event drew more than 600 participants to New Orleans.
Abstract describes efficacy of ocrelizumab in patients with PPMS with and without T1 gadolinium-enhancing lesions at baseline in a Phase III, placebo-controlled trial.
Environmental factors, genetics and epigenetics in multiple sclerosis susceptibility and clinical course is focus of ACTRIMS Forum 2017.
A new, highly effective multiple sclerosis therapy will be presented at the America’s Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2017, Thursday, Feb. 23, in Orlando.
The second annual ACTRIMS Forum gets underway today. This year, the forum was preceded by the Neurology Resident Summit in Neuroimmunology, which drew 47 residents from the United States and Canada.
Abstracts from Environmental Factors, Genetics and Epigenetics in MS Susceptibility and Clinical Course are now available at Multiple Sclerosis Journal.
ACTRIMS' third annual forum will be Feb. 1-3 in San Diego, California and will focus on therapeutic targets in multiple sclerosis with emphasis on disease-modifying therapies. New at the 2018 forum is the presentation by the National Multiple Sclerosis Society of the Barancik Prize for Innovation in Multiple Sclerosis Research, recognizing work in MS research that demonstrates outstanding innovation and originality.
New findings uncover the mechanisms by which gut bacteria can trigger inflammation in the brain and contribute to multiple sclerosis
Professor Robin Franklin to receive the 2017 Barancik Prize for pioneering work to restore function for people with progressive MS. He will receive the award at ACTRIMS Forum 2018 on February 1 in San Diego, California.
Late breaking abstracts
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) recognized the research contributions of five young investigators during the recent ACTRIMS Forum 2018. Abstracts and posters can be found in the ACTRIMS Forum online program, and will be published in the MS Journal.
Fourth annual Forum will be held Feb. 28-March 2 in Dallas, Texas.
Dr. Rhonda Voskuhl professor at the University of California, Los Angeles, will present her hypothesis that molecular mechanisms underlying each disability may differ from each other based on regional differences in neurons, astrocytes and oligodendrocytes as the subject of the keynote Kenneth P. Johnson Memorial Lecture on the opening day of the ACTRIMS Forum 2019.
Professor Katerina Akassoglou to receive 2018 Prize for work understanding the origins of nerve damage in MS and identifying potential therapies to stop it.
Approximately 1,200 researchers and clinicians are expected to attend the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum Feb. 27-29, 2020, in West Palm Beach, Florida.
Dr. Peter Calabresi, professor of Neurology and Neuroscience at the Johns Hopkins School of Medicine and Director of the Johns Hopkins Multiple Sclerosis (MS) Center, will present his team’s discovery of a possible link between severe damage and C3 and C1q gene variants, and how this information could lead to improvements in the ways MS and other neurodegenerative diseases are treated, during his keynote Kenneth P. Johnson Memorial Lecture on the opening day of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2020.
Dr. Francisco J. Quintana to receive the award and deliver the Barancik Prize lecture at the ACTRIMS Forum 2020 for work resulting in new tools and treatments to combat MS
Registered media to MSVirtual2020 will have access to the full program including plenary sessions, invited speakers and platform presentations of abstracts, poster presentations, teaching courses, and industry supported satellite symposia, both scheduled and on-demand
I am pleased to announce that the 8th Joint ACTRIMS-ECTRIMS Meeting will be held from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26.
The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26.
Multiple Sclerosis Facts and Figures
Multiple Sclerosis Facts and Figures
The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest international conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right